As previously mentioned, auto-inflammatory diseases characterized by STING overactivation and IFN-1 overexpression (e.g., SAVI and AGS) have more promising therapeutic targets. The gene discussed is STING1; the disease is STING-associated vasculopathy with onset in infancy.